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Abstract
Background: Despite the great advances in the understanding of programmed cell death, little
attention has been paid to the sequence of the events that characterise it. In particular, the course
of apoptotic events induced by microtubule-interfering agents such as taxanes is poorly
understood. In order to increase such knowledge, we studied a number of independent
biochemical and cytological modifications using cytometric methods in a bladder cancer cell line
treated with the second generation taxane, docetaxel.
Results: Within a few hours, drug treatment had induced mitochondrial membrane transition, cell
shrinkage and a decrease in granularity. Cell cycle was almost completely blocked in G2/M phase
within 24 hours. The hypodiploid peak started to become prominent 48 hours after the treatment.
At the same time, the appearance of a DNA ladder demonstrated caspase-dependent chromatin
fragmentation. Concurrently, specific cell surface modifications took place, involving at first
glycoprotein syalilation and later phospholipid asymmetry. DNA fragmentation was subsequently
detected by TUNEL assay. Over time, cell membranes became permeable to propidium iodide. A
very similar time-course of apoptotic events was found after treatment of a myelomonocytic cell
line with the same drug.
Conclusion: After discussing some characteristics of the methods employed and their limitations,
a succession of apoptotic events over time is suggested, in which the collapse of mitochondrial
transmembrane potential (∆ψm) is the earliest sign of apoptosis.
Background
Apoptosis is the most widespread form of cell death, char-
acterised by distinguished biochemical and morphologi-
cal events triggered by signalling cascades and finely
regulated by the products of oncogenes, tumour suppres-
sor genes, and apoptosis-specific genes. It has proven use-
ful to distinguish two main phases in apoptotic cell death:
induction and execution. Induction is controlled by a wide
range of mechanisms that involve either surface (extrin-
sic) signalling and subsequent signal transduction mech-
anisms, or internal (intrinsic) pathways leading to the
release of mitochondrial components. Both pathways
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converge in common events during the execution phase.
These events specifically characterise apoptotic cell death
and lead to the successful phagocytosis of cell corpses, still
surrounded by leak-proof membranes [1,2].
Both basic and clinically oriented studies require reliable
evaluation and quantification of apoptosis. In particular,
most chemotherapeutic drugs trigger apoptosis in actively
dividing cells. A good deal of information about their effi-
cacy and their therapeutic index may be obtained by the
identification of cell death mode (apoptosis vs. necrosis),
quantification of dead cells, and by understanding the
effect of the drug on the cell cycle.
The unique changes that characterise the apoptotic proc-
ess provide several features that permit the recognition
and quantitation of apoptotic cell death by cytometric
methods [3]. These methods have two important advan-
tages in that they are quantitative and allow the possibility
of evaluating multiple parameters, including cell cycle sta-
tus. Some of them exploit specific features that are a hall-
mark of apoptosis, such as DNA degradation – as revealed
by reduced binding of the intercalating fluorescent dye,
propidium iodide [4], by the labelling of DNA strand
breaks [5], or by the redistribution of membrane phos-
pholipids, which can be detected by tagged fluoro-
chromes [6]. A common parameter for distinguishing
between apoptosis and necrosis is the integrity of the cell
membrane, which blocks the entry of propidium iodide
in non-permeabilised cells [7]. In the course of signal
transduction that leads to apoptosis, mitochondria may
release pro-apoptotic molecules, a process accompanied
by loss of the transmembrane potential (∆ψm) that can be
detected by specific fluorescent markers [8]. The central-
role played by mitochondria in the control of both intrin-
sic and extrinsic apoptotic pathways is well known [9].
The aim of the present study was to determine the tempo-
ral succession of the main events that characterise taxane-
induced apoptosis in a cancer cell line. Taxanes induce
apoptosis by interfering with microtubule dynamics, in
particular by preventing tubulin depolymerisation.
Actively dividing cells are thus induced to undergo apop-
tosis, triggered by bcl-2 phosphorylation and involving
the activation of the c-Raf-1/Ras or the p53/p21WAF1/
CIP1 signalling pathway [10]. In epithelial cells, taxol
induces a cyclosporin A (CsA)-sensitive decrease in ψm
and a Ca2+ efflux from the mitochondria [11]. It has also
been suggested that changes in the microtubule structure
induced by taxanes may be responsible for opening the
mitochondrial permeability transition pores [12].
In this and in most drug-induced apoptotic processes, the
release of mitochondrial components is a requisite for the
activation of caspases, which are apoptosis-specific pro-
teases [13]. DNA fragmentation and most of the biochem-
ical and morphological changes that characterise
apoptosis then take place under the control of effector cas-
pases. However, the order of events has seldom been
investigated. We therefore evaluated a number of suppos-
edly independent apoptotic events and their temporal
succession in an attempt to determine which are actually
independent from the other.
A secondary aim of the study was to compare multiple
cytometric methods to study the apoptotic process and
acquire information that can be used as a guideline for the
choice of the most suitable parameter(s) for different
experimental systems. In particular, since some methods
actually assess the same event, we will discuss possible
discrepancies in results. These parameters can be
employed to assess the execution phase of apoptosis,
which is believed to take place in a stereotyped way, inde-
pendently of the apoptotic trigger [14].
Results
Antiproliferative and cytocidal effects
Docetaxel exerted an antiproliferative effect on HT 1376
tumour cell line at a concentration as low as 0.03 µg/mL
(Fig. 1). In fact, after either 24 hours' continuous exposure
to the drug or a 1-hour treatment followed by a 23-hour
wash-out, cell growth was greatly reduced compared to
that of unexposed cells. No dose-response relationship
was observed in the wash-out experiments, whereas con-
tinuous exposure to docetaxel (DOC) concentrations
higher than 0.03 µg/mL resulted in a more pronounced
cytostatic effect, as shown by a further decrease in cell
Cytotoxic and antiproliferative activity of docetaxel in the  HT1376 bladder cancer cell line, evaluated by Sulphorhod- amine B assay Figure 1
Cytotoxic and antiproliferative activity of docetaxel in the 
HT1376 bladder cancer cell line, evaluated by Sulphorhod-
amine B assay. The percentage of cell growth is defined in the 
Methods section. Continuous line: 1-hour treatment with 
docetaxel followed by a 23-hour wash-out. Dotted line: 24-
hour continuous treatment. Experiments were run in octu-
plet, and each experiment was repeated three times. Stand-
ard errors were below 5%BMC Cell Biology 2006, 7:6 http://www.biomedcentral.com/1471-2121/7/6
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growth as drug concentrations increased. One possible
interpretation is that DOC-induced growth arrest was
maximal even at the lowest concentration tested, but
affected, during the 1-hour exposure, only a fraction of the
cell population. Notably, SRB test was carried out for 24
hours only. It is likely that, if carried out for a longer time,
we would have observed a cytocidal effect, as suggested by
results from the other experimental procedures presented
in our study.
As the amount of DOC-induced necrosis was negligible
(see below), further experiments were carried out at the
highest DOC concentration (3 µg/mL, corresponding to
3.7 µM), in order to achieve more clear-cut results. More-
Cell cycle distribution of HT1376 bladder cancer cell line after a 1-hour treatment with 3 µg/mL docetaxel followed by differ- ent wash-out times Figure 2
Cell cycle distribution of HT1376 bladder cancer cell line after a 1-hour treatment with 3 µg/mL docetaxel followed by differ-
ent wash-out times. Cells were permeabilised and stained with propidium iodide, as described in the Methods section. Histo-
grams show a representative experiment.BMC Cell Biology 2006, 7:6 http://www.biomedcentral.com/1471-2121/7/6
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over, this concentration corresponds to the standard plas-
matic concentration achieved in in vivo treatments of
patients [15].
Cell cycle kinetics, apoptosis and scatter variation analysis
As shown in Fig. 2, DOC (3 µg/mL) induced a dramatic
accumulation of HT 1376 tumour cells in the G2/M com-
partment. Six hours after the beginning of treatment, the
G0/1 peak was already markedly reduced and by 24 hours
it had almost disappeared. The G2/M phase arrest was not
released for the 95 hours of recovery that followed DOC
treatment, whereas a hypodiploid sub-G0/1 peak was visi-
ble after 48 hours and gradually became more prominent,
thus indicating a massive apoptotic process. The apparent
increase in the G0/1 compartment observed subsequently
was due to the progressive loss of propidium iodide (PI)
stainability in cells undergoing apoptosis in the G2/M
phase. This demonstrates that DNA fragmentation, affect-
ing PI binding, occurs in G2-arrested cells.
Agarose gel DNA electrophoresis (Fig. 3) shows that chro-
matin underwent internucleosomal cleavage within 48
hours of treatment with DOC, as demonstrated by the for-
mation of the characteristic ladder pattern of DNA migra-
tion.
Forward and side scatter variation analysis (Fig. 4) shows
a reduction in cell volume and granularity in DOC-treated
cells as early as 16 hours after the beginning of treatment.
Shrinkage also occurred in controls, starting after about
48 hours of culture. This may be due to the fact that, by
that time, a reduction in growth rate was evident, as a con-
sequence of crowding (table 1). Nevertheless, after control
cultures were carried out for 96 hours without changing
the medium or splitting the flasks, apoptosis amounted to
about 10% and necrosis to a further 8% of cells (table 1).
However, only DOC-treated cells showed a reduction in
both forward and side scatter, a characteristic feature of
apoptotic cells. The percentage of cells with these features
gradually increased, reaching a plateau at 48 hours.
Mitochondrial pore transition
In cells with high mitochondrial membrane potential, the
fluorochrome JC-1 formed dye aggregates, which fluo-
resced red. Cells with low potential contained monomeric
JC-1 and fluoresced green. Thus, these reversible changes
in aggregation helped to identify cell status, as seen in Fig.
5, where DAPI staining reveals the nuclear fragmentation
in apoptotic cells, which showed a loss of mitochondrial
membrane potential.
Cytometric analysis shows that treatment of HT1376 cells
with DOC caused an early transition of JC-1 fluorescence,
with a shift toward green fluorescence that was detected as
early as 16 hours after treatment. The percentage of cells
DNA gel electrophoresis of docetaxel-treated (lanes 1–3)  and control (lane 4) HT1376 cells Figure 3
DNA gel electrophoresis of docetaxel-treated (lanes 1–3) 
and control (lane 4) HT1376 cells. DNA from HT1376 cells 
treated for 1 hour with 3 µg/mL docetaxel and cultured for a 
further 16, 24 and 48 hours was extracted as detailed in the 
Methods section, then separated in 1.5% agarose gel electro-
phoresis. DNA from a 72-hour control (untreated) culture 
was prepared in the same way.B
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Table 1: Percentage of apoptotic cells: comparison of results obtained with different methods in HT 1376 cells
UNTREATED CULTURES
METHOD CULTURE TIME
6 hrs 16 hrs 24 hrs 48 hrs 72 hrs 96 hrs 120 hrs
Cell Cycle HP G0/1 SG 2/M HP G0/1 SG 2/M HP G0/1 SG 2/MH PG 0/1 SG 2/M HP G0/1 SG 2/M HP G0/1 SG 2/M HP G0/1 SG 2/M
(PI staining) 1.0 42.6 37.4 20.0 1.0 44.0 35.4 20.6 2.0 47.9 30.5 21.6 2.6 60.5 31.0 8.5 2.1 64.5 25.7 9.8 3.3 70.1 19.3 10.6 5.6 78.1 12.3 9.6
6 hrs 16 hrs 24 hrs 48 hrs 72 hrs 96 hrs
JC-1 1.5 2.0 3.5 2.5 4.6 5.1
Low FSC area 4.4 5.6 8.9 11.8 10.8 30.7
Low FSC/SSC 
area
1.7 0.4 0.8 2.3 3.0 4.5
MAA+PI 
staining
ELN ELN ELN ELN ELN ELN
N.E. N.E. N.E. N.E. N.E. N.E. 0.5 0.6 5.4 1.5 1.3 7.2 3.1 3.4 10.6 5.0 5.8 10.8
AnnV+PI 
staining
ELN ELN ELN ELN ELN ELN
N.E. N.E. N.E. N.E. N.E. N.E. 2.9 0.7 4.5 2.0 3.2 5.1 1.2 4.7 7.3 3.1 5.9 8.2
TUNEL N.E. N.E. 0.5 0.8 1.6 1.5
DOCETAXEL-TREATED CULTURES
METHOD CULTURE TIME
6 hrs 16 hrs 24 hrs 48 hrs 72 hrs 96 hrs 120 hrs
Cell Cycle HP G0/1 SG 2/M HP G0/1 SG 2/M HP G0/1 SG 2/MH PG 0/1 SG 2/M HP G0/1 SG 2/M HP G0/1 SG 2/M HP G0/1 SG 2/M
(PI staining) 3.1 30.9 27.5 41.6 4.9 25.7 29.0 45.3 5.5 3.1 9.1 87.8 35.5 5.9 12.3 81.8 33.3 19.8 7.9 72.3 39.0 31.4 10.9 57.7 53.5 57.1 23.4 19.5
6 hrs 16 hrs 24 hrs 48 hrs 72 hrs 96 hrs
JC-1 3.0 10.4 24.5 53.6 60.0 91.3
Low FSC area 5.4 7.4 6.6 2.2 2.3 3.3
Low FSC/SSC 
area
6.5 8.5 24.2 29.6 32.5 33.6
MAA+PI 
staining
ELN ELN ELN ELN ELN ELN
N.E. N.E. N.E. N.E. N.E. N.E. 0.5 0.7 9.9 28.1 25.1 12.5 19.0 39.6 12.9 21.2 42.7 15.6
AnnV+PI 
staining
ELN ELN ELN ELN ELN ELN
N.E. N.E. N.E. N.E. N.E. N.E. 6.5 0.9 5.1 14.7 15.9 7.5 27.7 43.4 8.3 21.7 56.5 9.9
TUNEL N.E. N.E. 4.7 9.3 28.6 70.4
Top table: untreated (control) HT1376 bladder carcinoma cultures. Bottom table: HT1376 bladder carcinoma cultures were treated for 1 hour with 3 µg/mL docetaxel, after which the drug was 
washed out and the cells were further cultured. Figures are percentages of cells with the indicated characteristics. Data are the average of 3 independent experiments, with errors below 10%. 
For details, see the Methods section. N.E. = Not Examined; HP = Hypodiploid Peak; JC-1 = cells undergoing ∆ψm transition; E = early apoptosis, i.e. MAA+/PI- or AnnV+/PI-; L = late apoptosis, 
i.e. MAA+/PI+ or AnnV+/PI+; N = necrosis, i.e. MAA-/PI+ or AnnV-/PI+BMC Cell Biology 2006, 7:6 http://www.biomedcentral.com/1471-2121/7/6
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with impaired mitochondrial membrane potential stead-
ily increased, reaching 90% of cells 96 hours after treat-
ment (table 1).
For comparison purposes, the U937 myelomonocytic cell
line was treated for 1 hour with the same concentration of
DOC (3 µg/mL). The drug was then washed out and the
cells were cultured for a further 15, 23, or 47 hours,
stained with JC-1 and examined by cytometry. The mito-
chondrial pore transition was found to occur in U937 at
the same time as in HT 1376 cell line, i.e. as early as 15
hours after treatment (table 2).
To evaluate the effect of CsA-induced blockage of Ca2+
efflux from mitochondria, HT 1376 cells were pre-incu-
bated with 1 µM cyclosporin A (CsA) for 30 min before
treatment with DOC. CsA was washed out at the same
time as DOC, i.e. after a 1-hour exposure. Cells were
stained with JC-1 or AnnV + PI, as detailed in the Methods
section, immediately after the drug wash-out (1 hr) and
after a 16- and 24-hour incubation. Results showed that
CsA treatment did not affect the mitochondrial ∆ψ varia-
tion (table 3).
Necrosis
Double staining with MAA lectin or Annexin V (AnnV)
and PI allowed for the evaluation of necrosis (tables 1 and
2). After 96 hours of culture, DOC-treated HT 1376 cells
stained with PI alone (primary necrosis) accounted for
only 16% of the total cell population, a value just slightly
higher than that of control (untreated) cells. The percent-
age of DOC-treated PI+ U937 cells was also negligible.
This demonstrates that DOC induces cell death largely by
apoptosis.
Our results clearly show that cells labelled by an apoptosis
marker, such as AnnV, also tend to become permeable to
PI due to the loss of membrane integrity (tables 2 and 3).
MAA lectin
DOC-treated HT1376 cells developed affinity for MAA
lectin 24 to 48 hours after exposure to the drug (table 1).
When evaluated 48 hours after DOC treatment, more
than 50% of cells were found to be MAA+, but about half
of them had already lost their membrane integrity, under-
going secondary necrosis and becoming permeable to
propidium iodide. Over time, whilst more and more cells
underwent apoptosis and formerly apoptotic cells
acquired PI permeability, the percentage of MAA+/PI-
cells remained stable, whereas that of MAA+/PI+
increased, thus showing that MAA binding initially
occurred in apoptotic rather than necrotic cells.
DOC-treated U937 cells were also recognized by MAA lec-
tin, but at an earlier culture times (16 hours) than
HT1376. The percentage of MAA+ U937 cells steadily rose
as culture time increased, and a subset of MAA+ cells
became PI+.
Phosphatidylserine exposure
Forty-eight hours after DOC treatment, HT1376 cells
started displaying AnnV-staining above control levels
(table 1), but the percentage of AnnV+ cells was lower
than that of MAA+ cells, thus suggesting that phosphati-
dylserine (PS) exposure occurs later than carbohydrate
changes affecting MAA binding. Over time, as already seen
for MAA+ cells, the percentage of AnnV+/PI- cells
remained stable, whereas that of AnnV+/PI+ increased.
AnnV+ cells, whether PI- or PI+, outnumbered MAA+ cells
at 72 and 96 hours, thus indicating that a subset of AnnV+
cells did not bind MAA lectin.
DOC-treated U937 cells also displayed AnnV staining,
with a time course and cell percentages similar to those of
MAA staining (table 2). As culture time increased, a subset
of AnnV+ U937 cells became PI+. The fact that the time
course of MAA staining and the percentage of MAA+ cells
paralleled that of AnnV in both cell types reinforces the
hypothesis that MAA is a marker of apoptosis, detecting
the same cell subset as AnnV.
As the AnnV staining method requires incubation at room
temperature, at variance with the staining method for JC-
Double staining of nuclei (DAPI blue) and mitochondria (JC- 1) Figure 5
Double staining of nuclei (DAPI blue) and mitochondria (JC-
1). Left panel: control cells with intact nuclei, where JC-1 
aggregates inside healthy mitochondria and fluoresces red 
(arrows). Right panel: apoptotic HT1376 bladder cancer cells 
with fragmented nuclei, where the monomeric form of JC-1 
diffuses into the cytoplasm and fluoresces green (arrows). 
Cells in the right panel were treated with docetaxel (1 hour 
followed by a 96-hour wash-out). The aggregation of JC-1 in 
the mitochondria is driven by the transmembrane potential. 
Aggregated extracellular dye deposits (stars) are artifactual.BMC Cell Biology 2006, 7:6 http://www.biomedcentral.com/1471-2121/7/6
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1, we performed an experiment to evaluate whether a
mock incubation (no additions) mimicking JC-1 staining
at 37°C before staining with AnnV at room temperature
would alter the amount of apoptosis recognized by AnnV.
No variation in the percentage of AnnV+ apoptotic cells
was observed after a ten-minute incubation at 37°C.
Results are not reported for the sake of brevity.
Cell count and viability
To confirm data on cell cycle kinetics and to evaluate the
percentage of viable and non viable cells using an inde-
pendent method, an aliquot of control and DOC-treated
HT 1376 cells was stained with trypan blue and counted
at different culture times. Results are shown in table 4.
Newly-seeded control cells displayed a 1.85-fold increase
in number within the first 24 hours of culture. The dou-
bling time subsequently increased as a result of crowding,
but total cell count was about 5-fold higher than the ini-
tial one after 4 days of culture. Conversely, cell growth was
found to be impaired in DOC-treated cells with respect to
the first determination (1.42-fold increase within the first
24 hours). DOC-treated HT 1376 cells completed about
one round of duplication within the first 48 hours, but
did not show further growth. When evaluated at later
times, a slight reduction in the total cell count was seen
(about 23% after 96 hours of culture), probably due to the
fragmentation of apoptotic cells. These data confirm that
treatment with DOC results in cell cycle inhibition and in
a subsequent induction of cell death, as already shown by
the SRB test and by cell cycle kinetics (Fig. 1, 2).
Trypan blue stained only non viable cells, i.e. cells that
have lost their membrane integrity. On a time-by-time
basis, the percentage of non viable cells reported in table
3 corresponds to that obtained with PI staining reported
in table 1, i.e. the sum of AnnV+/PI+ and AnnV-/PI+ cells.
These data suggest that, using cytofluorimetric methods
alone, a comprehensive and reliable picture of both cell
cycle kinetics and cell viability can be obtained.
DNA strand breaks
TUNEL staining of HT1376 apoptotic cells, indicative of
massive DNA strand breaks, was not observed until 72
Variation in forward and side scatter of HT1376 bladder cancer cell line after a 1-hour treatment with 3 µg/mL docetaxel fol- lowed by different wash-out times Figure 4
Variation in forward and side scatter of HT1376 bladder cancer cell line after a 1-hour treatment with 3 µg/mL docetaxel fol-
lowed by different wash-out times. Diagrams show a representative experiment. Owing to a decrease in size and granularity, 
apoptotic cells progressively accumulate in the lower left area of the diagram, whereas the lower left corner corresponds to 
cell debris.BMC Cell Biology 2006, 7:6 http://www.biomedcentral.com/1471-2121/7/6
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hours after DOC treatment. The percentage of TUNEL+
cells had markedly increased after 96 hours of culture,
approaching that of AnnV+ cells (table 1). It is noteworthy
that DNA strand breaks were detected at earlier times with
other methods, such as PI staining (Fig. 2) and DNA lad-
der formation assay (Fig. 3).
Discussion
Despite the considerable amount of information on
apoptosis in tumour cell lines acquired from cytometry-
based studies, little attention seems to have been paid to
the time course of the main events that characterise the
apoptotic process, and in particular those induced by tax-
anes.
Earlier studies established that phosphatidylserine expo-
sure to the outer membrane leaflet occurs simultaneously
with chromatin condensation [16] and precedes DNA
fragmentation [17]. Other membrane changes, as shown
by an increase in Merocyanin 540 binding of apoptotic
cells [18-20], may not be independent of the phosphati-
dylserine contribution to the membrane lipid composi-
tion [21]. On the other hand, AnnV staining itself may be
lacking in certain apoptotic cell populations [20]. These
findings underline the need to evaluate multiple parame-
ters when assessing cell death. A number of studies have
addressed the issue of mitochondrial involvement in the
apoptotic process by evaluating ∆ψm decrease with differ-
ent dyes [22-24] inan attempt to establish a temporal –
and possibly – causal relationship within the events that
characterise apoptosis. It appears that the bcl-2 content of
the cells may be related to the timing of mitochondrial
involvement [25]. This consideration is particularly
important in taxane-induced apoptosis, where bcl-2 is
involved in the cell death induction mechanisms as well
as in drug resistance [26-28].
Taxanes and their derivatives inhibit microtubule
depolymerisation, thus preventing cell cycle completion
[29] and thus causing apoptotic cell death. A similar effect
is also caused by drugs that inhibit microtubule polymer-
isation, such as vinblastine and vincristine. Apoptosis trig-
gered by agents that disrupt microtubule organisation is
associated with bcl-2 phosphorylation and is independ-
ent of p53 involvement, at variance with apoptosis due to
DNA-damaging agents [30]. Despite these differences,
both microtubule disruption and DNA damage activate
the intrinsic pathway of cell death, causing the release of
mitochondrial components and the formation of apopto-
somes. In both cases, the triggering mechanism is believed
to involve changes in the amount and/or activity of anti-
and pro-apoptotic members of the bcl-2 family.
Conversely, it has been shown that administration of
paclitaxel – the prototype for taxane compounds – causes
an almost immediate increase in cytosolic Ca2+, associ-
ated with a rapid decline in mitochondrial membrane
potential, presumably due to the opening of the permea-
bility transition pores (mPTPs) [11,31]. The rapidity of
this event apparently rules out the participation of mech-
anisms controlling microtubule assembly status, thus sug-
gesting a pathway of death induction different from that
previously reported [30]. However, it is recognised that
loss of ∆ψm and variations in [Ca2+]i may be transient and
do not necessarily lead to apoptosis. In particular, mPTPs
have two conformations, one characterised by low- and
the other by high-conductance state [32]. The opening of
the former is reversible, allows the release of small mole-
cules only – such as calcium ions – and may be involved
in the rapid [Ca2+]i changes described by other authors
[11]. In contrast, late changes in ∆ψm, such as those
observed by us 16 hours after drug treatment, are likely to
involve the high-conductance mPTP, which is responsible
for the release of apoptosis-inducing compounds. The
delayed change in ∆ψm is not apparently affected by prior
exposure to CsA (table 3). However, it is obvious that cell
cycle is already deeply affected as early as 6 hours after the
end of drug treatment (Fig. 2). Thus, a more realistic view
puts the mitochondrial involvement in apoptosis down-
stream of paclitaxel-induced G2/M arrest. Within this cell-
Table 2: Percentage of apoptotic cells: comparison of results obtained with different methods in the U937 myelomonocytic cell line
Method Culture time
16 hrs 24 hrs 48 hrs Untreated controls, 48 hrs
JC-1 15.6 27.3 56.4 4.0
MAA + PI staining E L N E L N E L N E L N
18.4 2.0 4.6 23.8 4.4 8.4 38.0 29.0 6.5 1.0 1.5 5.6
Ann V + PI staining E L N E L N E L N E L N
19.5 6.5 1.2 28.7 10.1 3.5 40.9 22.0 2.8 2.9 1.5 1.8
U937 myelomonocytic cells were treated for 1 hour with 3 µg/mL docetaxel, after which the drug was washed out and cells were further cultured. 
Data are the average of 2 experiments, with nearly identical results. For details, see the Methods section.
JC-1 = cells undergoing ∆ψm transition; E = early apoptosis, i.e. MAA+/PI- or AnnV+/PI-; L = late apoptosis, i.e. MAA+/PI+ or AnnV+/PI+; N = 
necrosis, i.e. MAA-/PI+ or AnnV-/PI+BMC Cell Biology 2006, 7:6 http://www.biomedcentral.com/1471-2121/7/6
Page 9 of 14
(page number not for citation purposes)
cycle phase, microtubule impairment may activate mTOR
kinase, thus affecting bcl-2 phosphorylation and its subse-
quent proteasome-dependent degradation [33]. The data
on the action/activity of CsA presented in the present
study are only preliminary and the role played by Ca2+ var-
iation in this process will be the object of future investiga-
tion.
Whilst the time course of early events has yet to be
defined, its eventual clarification will provide new insight
into the mechanism whereby taxanes induce cell death.
Moreover, other well-studied events that belong to the
execution phase of apoptosis have not yet been placed in a
precise time setting. These include phosphatidylserine
exposure to the outer cell surface, DNA cleavage, and loss
of membrane integrity. Changes in surface glycosylation
are less well understood and have been included here
because they currently being studied by the authors
(Marini et al., manuscript in preparation). Our results sug-
gest that these changes are not peculiar to a given cell type
and potentially represent a new marker of apoptosis. They
would seem to occur about the same time as PS exposure
to the outer surface and may be related to it.
As described in the present work, apoptotic events in the
HT1376 bladder cancer cell line treated with DOC would
appear to occur in the following order: 1) cell cycle arrest;
2) loss of mitochondrial membrane potential; 3) cell
shrinkage and decrease in granularity; 4), DNA fragmen-
tation (hypodyploid peak and electrophoretic laddering);
5) and 6) change in syalilation of surface proteins and loss
of surface phospholipid asymmetry; 7) loss of membrane
integrity (cells become PI+); 8) further DNA fragmenta-
tion (TUNEL). The above outlined sequence of events
takes into account intrinsic limitations in cytometric
methods, which include a lesser degree of sensitivity in
comparison with biochemical determinations and the
variability in drug response within an asynchronous cell
population. In fact, it must be stressed that all the cells do
not die simultaneously after drug treatment because death
is dependent on factors such as the cell cycle status and the
individual energy level. Moreover, in most artificial sys-
tems, e.g. culture flasks, cells dying by apoptosis are not
phagocyted by competent cells and eventually lose their
membrane potential and undergo secondary necrosis.
Thus, within an asynchronously growing cell population,
cycling cells, cycle-arrested cells, cells undergoing apopto-
sis and cells already undergoing secondary necrosis can all
be found and will be sending out conflicting signals that
require interpretation.
Data on DOC-treated U937 myelomonocytic cell lines
were reported in the present work for comparison pur-
poses and were not as complete as those obtained on HT
1376 bladder cancer cell line. Nevertheless, they suggest
that ∆ψm is an early event in both cell types, that bear
though different they may be, and that MAA marks the
same cell subset as AnnV.
In permeabilised cells, DNA fragmentation results in
decreased PI staining (i.e. cells appear to have a hypodip-
loid DNA content) [7]. Accordingly, this event appears to
occur between 24 and 48 hours after drug administration.
However, the onset of DNA fragmentation may occur ear-
lier, as cells with duplicated DNA join the sub-G0/1 peak
after passing through the S and G0/1 peaks. On the other
hand, it is possible that, over time, the progressive
increase in DNA fragmentation causes a marked loss in PI
stainability, causing the hypodiploid peak to be underes-
timated, as suggested by comparing data with results
obtained from unpermeabilised cells and from TUNEL
staining, another index of DNA fragmentation. This tech-
nique, where 3' OH termini – resulting from DNA cleav-
age – are labeled with FITC-conjugated nucleotides in a
reaction utilising exogenous terminal deoxynucleotide
transferase (TdT), is apparently less sensitive than a
decrease in PI stainability, possibly because it requires
more extensive DNA cleavage. However, for longer culture
times, TUNEL staining appears to give a better estimate of
the percentage of apoptotic cells with respect to the evalu-
ation of the hypodiploid peak. In fact, 96 hours after DOC
treatment, the percentage of TUNEL+ cells was much
higher than that of cells in the sub-G0/1 peak, and approx-
imated that of AnnV+ cells.
The characteristic ladder revealed by gel electrophoresis of
DNA from DOC-treated cells demonstrates that chroma-
tin fragmentation did not occur randomly, but rather at
internucleosomal sites. Neither high molecular weight
DNA cleavage (as occurs during the initial stages of apop-
tosis), nor aspecific DNA fragmentation (following
necrotic cell death), produce such a specific pattern of
electrophoretic migration. The same applies to the forma-
tion of the hypodiploid peak [34].
Cell surface modifications were observed 24 hours after
DOC treatment and over time extended to other cells
(table 1). Due to its strong affinity to negatively charged
phospholipids, AnnV binds phosphatidylserine as it
becomes exposed to the outer cell surface, a common fea-
ture of cells undergoing apoptosis. Variations in cell sur-
face carbohydrate composition can be identified by
changes in lectin-mediated recognition. Apoptotic cells
may change the oligosaccharide composition of their gly-
cocalix, thus displaying a differential binding to some
lectins. In particular, Maakia Amurensis lectin (MAA),
which preferentially recognises galactose residues bound
to α 2,3 sialylic acid [35], was found to bind to apoptotic
cells rather than to their "healthy" counterpart (Marini et
al, manuscript in preparation). The percentage of cellsBMC Cell Biology 2006, 7:6 http://www.biomedcentral.com/1471-2121/7/6
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showing variations in the glycosylation of surface mole-
cules initially increased more sharply than that of cells dis-
playing phosphatidylserine on the outer membrane
leaflet. However, over time the percentage of MAA+ cells
did not reach that of AnnV+ cells. Studies are ongoing to
further the understanding of these variations in surface
syalilation and of their relevance in apoptosis. As already
pointed out, the cell population appeared to acquire both
MAA and AnnV markers before losing its membrane
integrity (i.e. before becoming permeable to PI). In addi-
tion to such information, the percentages of apoptotic PI-
and PI+ cells observed shows that the increase in TUNEL
positivity (i.e. progression in DNA degradation) also
occurred in cells that had lost membrane integrity.
Ninety-six hours after drug treatment, the near totality of
cells displayed a decrease in transmembrane mitochon-
drial potential ∆ψm that accompanied the efflux of pro-
apoptotic molecules from the mitochondrion, as evalu-
ated by the cationic fluorochrome JC-1 (table 1). This sug-
gests that almost all of the DOC-treated cells eventually
undergo apoptosis. Moreover, it supports the view
hypothesis that mitochondrial events occur very early dur-
ing cell culture and pave the way for both DNA cleavage
and surface modifications. Furthermore, cytoskeleton
modifications that cause cell shrinkage and loss of granu-
larity (Fig. 4) may be subsequent to a loss of ∆ψm, as sug-
gested elsewhere [36].
In the present paper we compared cytofluorimetric with
non cytofluorimetric methods of evaluation of cell death.
The same conclusions about the cytotoxic and cytostatic
effects of the drug were reached using the SRB assay, the
dye-exclusion test and the cytofluorimetric evaluation of
cell cycle. Apoptosis-induced cell surface and chromatin
modifications can be assessed by both morphological
evaluation and cytometry. However, cytometry appears to
be better suited for quantification purposes due to its sim-
plicity of use and to the wide range of applications that are
made possible by technical improvements.
Conclusion
Our data show that the taxane-induced cell cycle block
begins in the first few hours after DOC treatment, whereas
at that time only a minority of cells display a decrease in
∆ψm. These events suggest that the actual impairment in
the mitochondrial function, which initiates the apoptotic
process, has a later onset and follows the cell cycle block.
However, as already highlighted, this impairment is of
great importance because, over time, the near totality of
DOC-treated cells that presented a loss in ∆ψmeventually
undergoes apoptosis.
By evaluating different cytometric methods concomi-
tantly, we were able to draw up a chronological table of
apoptotic events in taxane-induced cell death, where G2/
M arrest appears to precede mitochondrial involvement,
which occurs before DNA fragmentation and cell surface
modifications. The present study also provides a sort of
time-based guideline for the choice of the most appropri-
ate parameters to detect specific apoptotic modifications,
Table 3: Effect of pre-incubation with CsA on DOC-treated HT 1376 cells.
1 h 16 hrs 24 hrs
Control
JC-1 1.0 2.1 4.7
AnnV + PI staining E L N E L N E L N
1.9 0.5 1.5 2.1 0.9 3.1 2.8 1.1 5.0
DOC-treated
JC-1 1.0 9.5 24.0
AnnV + PI staining E L N E L N E L N
2.1 0.9 2.0 5.0 0.5 3.5 6.0 2.5 5.5
CsA + DOC treated
JC-1 1.0 5.2 23.1
AnnV + PI staining E L N E L N E L N
2.0 0.7 2.5 5.0 1.1 4.2 5.0 4.3 8.4
HT 1376 bladder carcinoma cells were pre-incubated for 30 min with 1 µM CsA, after which 3 µg/mL docetaxel was added. After a 1-h treatment, 
both drugs were washed out and cells were further cultured. Data are percentages of cells with the indicated staining characteristics. For details, 
see the Methods section.
JC-1 = cells undergoing ∆ψm transition; E = early apoptosis, i.e. AnnV+/PI-; L = late apoptosis, i.e. AnnV+/PI+; N = necrosis, i.e. AnnV-/PI+BMC Cell Biology 2006, 7:6 http://www.biomedcentral.com/1471-2121/7/6
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such as cell surface changes or early/initial vs. late/massive
DNA fragmentation.
In conclusion, we believe that the effects of a particular
drug on a cell culture can best be investigated by using
multiple parameters to assess apoptosis, by following
them up for a relatively long time, and by comparing the
dynamics of treated and untreated cell populations. Hav-
ing said that, some information may still be missing, such
as the absolute number of disintegrated cells, as there is no
way of relating the amount of cell debris to that of the cells
which originated them. On the other hand, a fairly simple
assay such as cell cycle distribution and its evolution over
time may be sufficiently informative to determine
whether or not a drug warrants further investigation.
Methods
Materials
Unless otherwise specified, all reagents were purchased
from Sigma-Aldrich (St. Louis, MO, USA).
Cell lines
Most studies were performed on a bladder carcinoma cell
line, HT1376, obtained from the American Type Culture
Collection (Rockville, MD, USA). Cells were maintained
as a monolayer at 37°C in a humidified atmosphere of
5% CO2 in air and subcultured weekly. Culture medium
was composed of DMEM/HAM F12 (1:1) supplemented
with foetal calf serum (10%), glutamine (2 mM), non-
essential aminoacids (1%) (Mascia Brunelli s.p.a., Milan,
Italy), and insulin (10 mg/mL). Cells were used in the
exponential growth phase in all the experiments.
Some experiments were performed on U937 myelomono-
cytic cell line, obtained from the same source. Cells were
grown as liquid cultures at 37°C in a humidified atmos-
phere of 5% CO2 in air and subcultured every three days.
Culture medium was RPMI 1640 (Biowhittakers, Verviers,
Belgium) supplemented with foetal calf serum (10%),
glutamine (2 mM), penicillin (100 IU/L), and streptomy-
cin (0.1 g/L).
Cell treatments
DOC was obtained from Aventis Pharma S.A. (Paris,
France). The drug was stored at a concentration of 10 mg/
mL (12.6 mM) in 13% w/w ethanol at 4°C and diluted in
medium before use. The final concentration of ethanol in
the medium never exceeded 0.01%, and therefore had no
effect on cell growth and viability. Control cells received
the same amount of solvent.
After performing an initial evaluation of drug cytotoxicity
by treating the cell cultures with DOC at concentrations
ranging from 0.03 to 3 µg/mL, the highest dose was used
in all subsequent experiments.
Chemosensitivity assay
The Sulforhodamine B (SRB) assay was used according to
the method by Skehan et al. [37]. Briefly, cells were col-
lected by trypsinisation, counted and plated at a density of
10,000 cells/well in 96-well flat-bottomed microtitre
plates (100 µl of cell suspension/well). In the chemosen-
sitivity assay, DOC was tested at scalar concentrations
ranging from 0.03 µg/mL to 3 µg/mL (3.7 µM) for 24
hours or for 1 hour followed by 23-hour culture in drug-
free medium. Experiments were run in octuplet, and each
experiment was repeated three times. The optical density
(OD) of treated cells was determined at a wavelength of
540 nm by means of a fluorescence plate reader. Growth
inhibition and cytocidal effect of the drug were calculated
according to the formula reported by Monks et al. [38]:
[(ODtreated - ODzero)/(ODcontrol - ODzero)] × 100%, when
ODtreated is > to ODzero. If ODtreated is above ODzero, treat-
ment induced a cytostatic effect, whereas if ODtreated is
below ODzero, cell killing has occurred. The ODzero depicts
the cell number at the moment of drug addition, the
ODcontrol reflects the cell number in untreated wells and
the ODtreated reflects the cell number in treated wells on
the day of the assay. In this way, if a drug does not affect
cell growth or viability, the test outcome will be 100. Con-
versely, if it induces a cytostatic effect, the result will be
between 0 and 100 (upper part of the diagram), whereas
if it induces a cytocidal effect, the result will be between 0
and -100 (lower part of the diagram), indicating that the
number of cells at the end of the observation time is lower
than the initial one.
Induction of apoptosis
Induction of apoptosis was tested at a concentration of 3
µg/mL (3.7 µM) DOC for 1 hour followed by a 6-, 24-, 48-
72- and 96-hour culture in drug-free medium. Data are
the average of two to three experiments, with errors under
10%.
Cyclosporin A treatment
Cyclosporin A (CsA) is the most widely used blocker of
calcium efflux from the mitochondria. For this prelimi-
nary experiment we used a concentration of 1 µM [39].
CsA was added to HT 1376 cells 30 min before DOC treat-
ment. After a 1-hour incubation, both drugs were washed
out. Evaluation of JC-1, AnnV and PI staining was carried
out immediately after the end of drug exposure and after
a 16- and 24-hour culture in drug-free medium. Control
(untreated) and DOC-treated cultures were run in parallel
and evaluated at the same times as CsA+DOC-treated cul-
tures.
Flow cytometry
For cytofluorimetric evaluations, the medium was
removed at the indicated wash-out times and cells were
detached from the flasks by trypsin treatment, washedBMC Cell Biology 2006, 7:6 http://www.biomedcentral.com/1471-2121/7/6
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twice with PBS and stained according to the different
methods specified below. A FACS Vantage flow cytometer
(Becton Dickinson, San Diego, CA, USA), equipped with
an argon laser (488 nm) was used. Data acquisition and
analysis were performed using CELLQuest Pro software
(Becton Dickinson, San Diego, CA, USA).
Cell cycle distribution
Cell cycle distribution and percentage of cells within the
sub-G1 peak (i.e. with fragmented DNA) were estimated
by PI staining. Cells (1 × 106/mL) were fixed in 70% eth-
anol, washed twice in PBS, then incubated overnight at
4°C in the dark in a PBS solution containing propidium
iodide (10 µg/mL), RNAse (10 Kunits/mL) and NP40
(0.01%). Data were elaborated using Modfit software
(DNA Modelling System, Verity Software House, Inc.,
Topsham, ME, USA) and expressed as fractions of cells in
the different cycle phases. Samples were run in triplicate,
and each experiment was repeated three times. Diagrams
of growing cultures display the characteristic x-axis distri-
bution according to the DNA content, the first peak corre-
sponding to the diploid (2c) peak, i.e. to cells in the G0/1
phase, and the second peak to cells with 4c DNA content,
i.e. to cells in G2/M phase. Cells with an intermediate
DNA content are in the S phase. When DNA is frag-
mented, as in apoptotic cells, the affinity with the interca-
lating PI dye is decreased and a so-called hypodiploid
peak (or area) becomes apparent to the left of the G0/1
peak.
JC-1
The cationic fluorochrome JC-1 (BD Biosciences
Pharmingen, San Diego, CA, USA) was used to evaluate
the decrease in transmembrane mitochondrial potential
(∆ψm) that accompanies the efflux of pro-apoptotic mol-
ecules fromthe mitochondrion. JC-1 forms aggregates that
fluoresce red in the presence of high mitochondrial mem-
brane potential, as in normal cells. When mitochondrial
membrane potential decreases, as occurs when mitochon-
drial pores open during the apoptotic process [8,9], JC-1
becomes monomeric and fluoresces green.
After DOC treatments, cells were harvested, washed once
in PBS and then immediately incubated in JC-1 working
solution containing 1 µM JC-1 monomer at a concentra-
tion of 1 × 106 cells/mL for 15 min in a humidified atmos-
phere at 37°C in the dark, according to the manufacturers'
instructions. Cells were then washed twice, resuspended
in Assay Buffer and analysed by flow cytometry. For each
sample, 15,000 events were recorded.
Propidium iodide staining
The DNA-intercalating dye, propidium iodide, does not
permeate viable cells. Therefore, when added to unperme-
abilised cells, it is possible to assess the amount of necro-
sis in a cell population. When used in combination with
a marker of apoptosis, it permits detection of so-called
"secondary necrosis" or "late apoptosis", i.e. the phenom-
enon whereby apoptotic cells, over time, lose their mem-
brane integrity. Thus, cells that are stained by PI alone
have undergone bona fide necrotic cell death, whereas PI+
cells that are also stained with a marker of apoptosis can
be classified as apoptotic. PI was added to a final concen-
tration of 5 µg/mL immediately before cytometric evalua-
tion (longer incubation times may cause aspecific
staining).
Lectin staining
MAA lectin binds to 2,3-linked syalil residues on cell sur-
face. Cells (5 × 105) were stained for 15 min in the dark at
room temperature with 1.5 µg FITC-conjugated MAA lec-
tin [40] dissolved in 100 µL PBS. Cells were thenwashed
twice in PBS and fixed in a 0.74% solution of formalde-
hyde in PBS. Immediately before cytometric analysis, pro-
pidium iodide was added to a final concentration of 5 µg/
mL to distinguish between early (PI-) and necrotic or late
(PI+) apoptotic cells. For each sample, 15,000 events were
recorded.
Table 4: Cell count and viability
Untreated HT1376 cells 6 hrs 16 hrs 24 hrs 48 hrs 72 hrs 96 hrs
Total cell count (106/mL) 5.625 9.375 10.42 17.3 23.625 27.25
% Viable cells 97.0 98.1 95.5 93.0 94.5 91.3
% Dead cells 3.0 1.9 4.5 7.0 5.5 8.7
DOC – treated HT1376 cells 6 hrs 16 hrs 24 hrs 48 hrs 72 hrs 96 hrs
Total cell count (106/mL) 4.281 6.887 7.706 10.545 9.647 8.557
% Viable cells 96.5 94.8 95.0 70.3 46.7 32.6
% Dead cells 3.5 5.2 5.0 29.7 53.3 67.4
HT 1376 bladder carcinoma cells were stained with Trypan Blue and evaluated with a hemocytometer, as described in Methods. Data reported in 
the table are from one representative experiment. Counting error was ± 0.15 × 106 cells. The count was repeated once, with virtually identical 
results.BMC Cell Biology 2006, 7:6 http://www.biomedcentral.com/1471-2121/7/6
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Annexin V assay
Annexin V binds to phosphatidylserine, a lipid compo-
nent of the plasma membrane that is flopped from the
inner to the outer cell surface during apoptosis and is
believed to play a role as an "eat-me" signal [41].
After DOC treatments, cells were harvested, washed once
in PBS and incubated with 5 µl/mL Annexin V-FITC in
binding buffer (Bender MedSystems, Vienna, Austria) for
10 min at room temperature in the dark. Cells were then
washed in PBS and suspended in binding buffer. Immedi-
ately before flow cytometry analysis, propidium iodide
was added to a final concentration of 5 µg/mL to distin-
guish between early (PI-) and necrotic or late (PI+) apop-
totic cells. For each sample, 15,000 events were recorded.
TUNEL assay
In the TUNEL assay, 3' OH termini, resulting from DNA
cleavage, are labelled with FITC-conjugated nucleotides in
a reaction utilsing exogenous terminal deoxynucleotide
transferase (TdT).
After DOC treatments, cells were harvested, fixed in 1%
paraformaldehyde in PBS on ice for 15 min, suspended in
ice cold ethanol (70%) and stored overnight at -20°C.
Cells were then washed twice in PBS and incubated with
50 µl of solution containing TdT and FITC-conjugated
dUTP (Roche Diagnostic GmbH, Mannheim, Germany)
in a humidified atmosphere for 60 min at 37°C in the
dark. Samples were then washed in PBS containing Triton
X-100 (0.1%), counterstained with 3 µg/mL propidium
iodide and RNase (10 Kunits/mL) for 30 min at 4°C in
the dark, and finally analysed by flow cytometry. For each
sample, 10,000 events were recorded.
Cell count and viability assay
HT1376 cells were seeded in duplicate at a concentration
of 2 × 105 cells/ml in 35-mm well dishes. At the indicated
times, cells were detached by trypsin treatment, washed
and resuspended in PBS. An aliquot of the cell suspension
was combined with an equal volume of 0.4% Trypan Blue
and incubated for 8–10 min. at 37°C. Cells were counted
in a counting chamber (Kova Glasstic Slide Hemocytom-
eter, Hycor Biomedical Inc., Garden Groove, USA). Both
total cell count and the percentage of viable and non via-
ble cells were recorded. Cells are considered to be viable
when they exclude the dye.
DNA gel electrophoresis
In the course of the apoptotic process, DNA is cleaved in
a distinctive way at internucleosomal sites by a specific
caspase-activated endonuclease [42], thus yielding frag-
ments in multiples of 200 bp, which appear as a character-
istic "ladder" when DNA is separated by gel
electrophoresis.
Fragmented DNA was isolated from samples of 2 × 106
cells as described by Zhivotovsky [42]. Electrophoresis
was carried out in 1.5% agarose gel.
Morphological investigation
After DOC exposure, samples were immediately stained
with the cationic fluorochrome JC-1 as described above
and with the cell-permeable dye 4',6-DAPI 10 µL/mL
(Molecular Probes, Leiden, The Netherlands). Cells were
fixed in ethanol (70%) and then examined under a fluo-
rescence photomicroscope (Zeiss, Axioscope 40) to visu-
alise the mitochondrial membrane depolarisation and
concurrently the chromatin condensation and/or frag-
mentation typical of apoptotic cells.
List of abbreviations used
DOC, docetaxel; SRB, Sulforhodamine B; MAA, Maakia
Amurensis lectin; AnnV, Annexin V; PI, propidium iodide;
PS, phosphatidylserine; mPTP, mitochondrial permeabil-
ity transition pore; PBS, phosphate-buffered saline.
Authors' contributions
All authors were involved in study design and planning of
the experiments, under the supervision of WZ and MM,
who acted as scientific advisors. FF was responsible for
coordinating the laboratory work and for data analysis; he
also performed most of the cytometry analysis. SC, GB
and RL performed the in vitro experiments. MM was
responsible for drafting the paper. All authors read and
approved the final manuscript.
Acknowledgements
This work was supported by grants from the Italian Ministry of University 
and Research, Istituto Oncologico Romagnolo, and the Italian Ministry of 
Health, 2002. The authors wish to thank. Kristine Lotito and Gráinne Tier-
ney for proofreading the manuscript and Anna Tesei for technical help.
References
1. Arends MJ, Wyllie AH: Apoptosis: mechanisms and roles in
pathology.  Int Rev Exp Pathol 1991, 32:223-254.
2. Hacker G: The morphology of apoptosis.  Cell Tissue Res 2000,
301:5-17.
3. Gorczyca W: Cytometric analyses to distinguish death proc-
esses.  Endocr Relat Cancer 1999, 6:17-19.
4. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid
and simple method for measuring thymocyte apoptosis by
propidium iodide staining and flow cytometry.  J Immunol Meth-
ods 1991, 139:271-279.
5. Kasagi N, Gomyo Y, Shirai H, Tsujitani S, Ito H: Apoptotic cell
death in human gastric carcinoma: analysis by terminal
deoxynucleotidyl transferase-mediated dUTP-biotin nick
end labeling.  Jpn J Cancer Res 1994, 85(9):939-945.
6. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC,
LaFace DM, Green DR: Early redistribution of plasma mem-
brane phosphatidylserine is a general feature of apoptosis
regardless of the initiating stimulus: inhibition by overex-
pression of Bcl-2 and Abl.  J Exp Med 1995, 182:1545-1556.
7. Zamai L, Falcieri E, Marhefka G, Vitale M: Supravital exposure to
propidium iodide identifies apoptotic cells in the absence of
nucleosomal DNA fragmentation.  Cytometry 1996, 23:303-311.
8. Cossarizza A, Kalashnikova G, Grassilli E, Chiappelli F, Salvioli S, Capri
M, Barbieri D, Troiano L, Monti D, Franceschi C: MitochondrialPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Cell Biology 2006, 7:6 http://www.biomedcentral.com/1471-2121/7/6
Page 14 of 14
(page number not for citation purposes)
modifications during rat thymocyte apoptosis: a study at the
single cell level.  Exp Cell Res 1994, 214:323-330.
9. Ravagnan L, Roumier T, Kroemer G: Mitochondria, the killer
organelles and their weapons.  J Cell Physiol 2002, 192:131-137.
10. Wang LG, Liu XM, Kreis W, Budman DR: The effect of antimicro-
tubule agents on signal transduction pathways of apoptosis:
a review.  Cancer Chemother Pharmacol 1999, 44:355-361.
11. Kidd JF, Pilkington MF, Schell MJ, Fogarty KE, Skepper JN, Taylor CW,
Thorn P: Paclitaxel affects cytosolic calcium signals by open-
ing the mitochondrial permeability transition pore.  J Biol
Chem 2002, 277:6504-6510.
12. Mironov SL, Ivannikov MV, Johansson M: [Ca2+]i signaling
between mitochondria and endoplasmic reticulum in neu-
rons is regulated by microtubules.  J Biol Chem 2005,
280:715-721.
13. Tsujimoto Y, Shimizu S: Bcl-2 family: life-or-death switch.  FEBS
Lett 2000, 466:6-10.
14. Wyllie AH: Apoptosis.  Br J Cancer 1993, 67:205-208.
15. Baker SD, Zhao M, Lee CK, Verweij J, Zabelina Y, Brahmer JR, Wolff
AC, Sparreboom A, Carducci MA: Comparative pharmacokinet-
ics of weekly and every-three-weeks docetaxel.  Cancer Res
2004, 10:1976-1983.
16. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST,
van Oers MH: V for flow cytometric detection of phosphatidyl-
serine expression on B cells undergoing apoptosis.  Blood 1994,
84:1415-1420.
17. O'Brien IEW, Reutelingsperger CPM, Holdaway KM: The use of
Annexin-V and TUNEL to monitor the progression of apop-
tosis in plants.  Cytometry 1997, 29:28-33.
18. Mower DA Jr, Peckham DW, Illera VA, Fishbaugh JK, Stunz LL, Ash-
man RF: Decreased membrane phospholipid packing and
decreased cell size precede DNA cleavage in mature mouse
B cell apoptosis.  J Immunol 1994, 152:4832-4842.
19. Chiu L, Cherwinski H, Ransom J, Dunne JF: Flow cytometric ratio
analysis of the Hoechst 33342 emission spectrum: multipar-
ametric characterization of apoptotic lymphocytes.  J Immunol
Methods 1996, 189:157-171.
20. Frey T: Correlated flow cytometric analysis of terminal
events in apoptosis reveals the absence of some changes in
some model systems.  Cytometry 1997, 28:253-63.
21. Rozalski M, Waczulikova I, Rievaj J, Nagyova K, Bryszewska M, Watala
C:  The contribution of phosphatidylserine partition and
transmembrane potential to the interaction of merocyanine
540 with lipid bilayers.  Cell Mol Biol Lett 2002, 7:297.
22. Vayssiere JL, Petit PX, Risler Y, Mignotte B: Commitment to apop-
tosis is associated with changes in mitochondrial biogenesis
and activity in cell lines conditionally immortalized with sim-
ian virus 40.  Proc Natl Acad Sci U S A 1994, 91:11752-11756.
23. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere JL, Petit PX,
Kroemer G: Reduction in mitochondrial potential constitutes
an early irreversible step of programmed lymphocyte death
in vivo.  J Exp Med 1995, 181:1661-1672.
24. Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A: JC-1, but not
DiOC6(3) or rhodamine 123, is a reliable fluorescent probe
to assess delta psi changes in intact cells: implications for
studies on mitochondrial functionality during apoptosis.  FEBS
Letters 1997, 411:77-82.
25. Zheng A, Mäntymaa P, Säily M, Siitonen T, Savolainen E-R, Koistinen
P: An association between mitochondrial function and all-
trans retinoic acid-induced apoptosis in acute myeloblastic
leukaemia cells.  Br J Haematol 1999, 105:215-224.
26. Haldar S, Basu A, Croce CM: Serine-70 is one of the critical sites
for drug-induced Bcl2 phosphorylation in cancer cells.  Cancer
Res 1998, 58:1609-1615.
27. Ferlini C, Raspaglio G, Mozzetti S, Distefano M, Filippetti F, Martinelli
E, Ferrandina G, Gallo D, Ranelletti FO, Scambia G: Bcl-2 down-reg-
ulation is a novel mechanism of paclitaxel resistance.  Mol
Pharmacol 2003, 64:51-58.
28. Inoue Y, Gika M, Abiko T, Oyama T, Saitoh Y, Yamazaki , Nakamura
M, Abe Y, Kawamura M, Kobayashi K: Bcl-2 overexpression
enhances in vitro sensitivity against docetaxel in non-small
cell lung cancer.  Oncol Rep 2005, 13:259-264.
29. Rowinsky EK, Onetto N, Canetta RM, Arbuck SG: Taxol: the first
of the taxanes, an important new class of antitumor agents.
Semin Oncol 1992, 19:646-662.
30. Haldar S, Basu A, Croce CM: Bcl2 is the guardian of microtubule
integrity.  Cancer Res 1997, 57:229-233.
31. Kroemer G, Reed J: Mitochondrial control of cell death.  Nature
Med 2000, 6:513-518.
32. Ichas F, Mazat JP: From calcium signaling to cell death: two
conformations for the mitochondrial permeability transition
pore. Switching from low- to high-conductance state.  Biochim
Biophys Acta 1998, 1366:33-50.
33. Asnaghi L, Bruno P, Priulla M, Nicolin A: mTOR: a protein kinase
switching between life and death.  Pharmacol Res 2004,
50:545-549.
34. Marini M, Frabetti F, Canaider S, Dini L, Falcieri E, Poirier GR: Mod-
ulation of caspase-3 activity by zinc ions and by the cell redox
state.  Exp Cell Res 2001, 266:323-32.
35. Wolosin JM, Wang Y: Alpha-2,3 sialylation differentiate the lim-
bal and corneal epithelial cell phenotypes.  Invest Ophthalmol Vis
Sci 1995, 36:2277-2286.
36. Curtis MJ, Wolpert TJ: The victorin-induced mitochondrial per-
meability transition precedes cell shrinkage and biochemical
markers of cell death, and shrinkage occurs without loss of
membrane integrity.  Plant J 2004, 38:244-259.
37. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D,
Warren JT, Bokesch H, Kenney S, Boyd MR: New colorimetric
cytotoxicity assay for anticancer-drug screening.  J Natl Cancer
Inst 1990, 82:1107-1112.
38. Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D,
Hose C, Langley J, Cronise P, Vaigro-Wolff A: Feasibility of a high-
flux anticancer drug screen using a diverse panel of cultured
human tumor cell lines.  J Natl Cancer Inst 1991, 83:757-766.
39. Detaille D, Guigas B, Chauvin C, Batandier C, Fontaine E,
Wiernsperger N, Leverve X: Metformin prevents high-glucose-
induced endothelial cell death through a mitochondrial per-
meability transition-dependent process.  Diabetes 2005,
54:2179-2187.
40. Hoebeke J, Foriers A, Schreiber AB, Strosberg AD: Equilibrium and
kinetic studies of the binding of Lens culinaris lectin to rabbit
erythrocytes by a quantitative fluorometric method.  Bio-
chemistry 1978, 17:5000-5005.
41. Savill J, Fadok V: Corpse clearance defines the meaning of cell
death.  Nature 2000, 407:784-788.
42. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S:
A caspase-activated DNase that degrades DNA during apop-
tosis, and its inhibitor ICAD.  Nature 1998, 391:43-50.
43. Zhivotovsky B, Nicotera P, Bellomo G, Hanson K, Orrenius S: Ca2+
and endonuclease activation in radiation-induced lymphoid
cell death.  Exp Cell Res 1993, 207:163-170.